By Ben Hirschler AMSTERDAM (Reuters) - A new clot preventer from Daiichi Sankyo proved as effective as widely used warfarin in treating a dangerous condition known as venous thromboembolism and caused less bleeding, a large clinical trial found. The Japanese drugmaker hopes the finding will help it take on rivals including Bayer, Johnson & Johnson, Pfizer and Bristol-Myers Squibb in a growing market for novel pills to prevent blood clots. Industry analysts believe that modern blood thinners to replace warfarin could generate annual sales of more than $10 billion a year. ...
via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment